Search Results - "Grootscholten, M.C."

LBA7 Neoadjuvant immune checkpoint inhibition in locally advanced MMR-deficient colon cancer: The NICHE-2 study by Chalabi, M., Verschoor, Y.L., van den Berg, J., Sikorska, K., Beets, G., Lent, A.V., Grootscholten, M.C., Aalbers, A., Buller, N., Marsman, H., Hendriks, E., Burger, P.W.A., Aukema, T., Oosterling, S., Beets-Tan, R., Schumacher, T.N., van Leerdam, M., Voest, E.E., Haanen, J.B.A.G.

Get full text

1219P Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction (G/GEJ) adenocarcinoma: The PANDA study by Chalabi, M., Verschoor, Y.L., Van De Haar, J., van den Berg, J., Kodach, L., van Sandick, J., van Dieren, J., Balduzzi, S., Grootscholten, M.C., Veenhof, X., Hartemink, K., Vollebergh, M., Owers, E., Bartels-Rutten, A., den Hartog-Lievaart, P., van Leerdam, M., Schumacher, T.N., Haanen, J.B.A.G., Voest, E.E.

Get full text

1260TiP The efficacy of the addition of TRAstuzumab and Pertuzumab to neoadjuvant chemoradiation: A randomized multi-center study in resectable HER2 overexpressing adenocarcinoma of the esophagus or gastroesophageal junction (TRAP-2) by Blangé, D., Hulshof, M.C.C.M., van Berge Henegouwen, M.I., Mostert, B., Slingerland, M., Haj Mohammad, N., Grootscholten, M.C., Creemers, G-J.M., Mekenkamp, L.J.M., Fiets, E., De Haan, J.J., Jeene, P., Rozema, T., Berbee, M., Beeker, A., Beerepoot, L.V., Derks, S., Bijlsma, M.F., van Grieken, N., van Laarhoven, H.W.M.

Get full text